The four cost paths for Bydureon BCise
Most Bydureon BCise users pay one of four prices: retail without insurance(the manufacturer's list price), commercial insurance with prior authorization (your copay tier), manufacturer savings card (commercial-insured eligible only), or partner network cash-pay (telehealth provider monthly subscription). Each path has different eligibility and dramatically different out-of-pocket cost.
1. Retail without insurance
Bydureon BCise's manufacturer list price runs approximately $870/monthat most US retail pharmacies (CVS, Walgreens, Walmart, Rite Aid). This is the price before any insurance or discount card applies. Most patients never pay this price — but it's the baseline reference.
2. Commercial insurance (with prior authorization)
Commercial insurance plans (Aetna, Cigna, UnitedHealthcare, Blue Cross Blue Shield, etc.) typically require prior authorization for Bydureon BCise. Approval criteria vary by plan but commonly require: a diagnosis matching the FDA-approved indication, documented BMI history, and evidence of prior failed weight-loss interventions. Once approved, copay tiers run roughly $25–$75/month (tier 2-3) to $100–$300/month (tier 4 specialty). Medicare Part D coverage for GLP-1s is limited — see our without insurance guide.
3. Manufacturer savings card
AstraZenecamay offer a copay card or savings program for eligible commercial-insurance patients. Check the manufacturer's direct website for current offers — these change frequently.
4. Partner network cash-pay
Telehealth partner networks (Henry Meds, Mochi Health, Ro, LifeMD, Eden, and similar) offer all-inclusive monthly subscriptions that bundle the consultation, prescription, and medication. Partner prices typically range $199–$899/month for the GLP-1 family. Compounded versions of Bydureon BCise (where available) are often cheaper but not FDA-approved — see our medical disclaimer.